Search Results - "Bumma, C"

Paclitaxel and carboplatin for recurrent salivary gland malignancies by Airoldi, M, Fornari, G, Pedani, F, Marchionatti, S, Gabriele, P, Succo, G, Bumma, C

“…The use of chemotherapy for recurrent salivary gland carcinomas is under investigation. Fourteen patients (10 males, 4 females; median age 55 years, range…”
Get more information

Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma by Katsaros, D., Oletti, M. V., Rigault de la Longrais, I. A., Ferrero, A., Celano, A., Fracchioli, S., Donadio, M., Passera, R., Cattel, L., Bumma, C.

“…Background: This multicenter phase II study evaluated feasibility, clinical efficacy, toxicity and pharmacokinetics of the combination of pegylated liposomal…”
Get full text

Ifosfamide in the treatment of head and neck cancer by Airoldi, M, Cortesina, G, Giordano, C, Pedani, F, Bumma, C

“…Ifosfamide (IFO) has demonstrated activity in recurrent/metastatic squamous cell head and neck carcinoma with an overall response rate of 24-26%. Better…”
Get more information

Multimodal treatment with primary single-agent epirubicin in operable breast cancer: 5-year experience of the Michelangelo Cooperative Group by Bonadonna, G., Zambetti, M., Bumma, C., Donadio, M., Bolognesi, A., Robustelli della Cuna, G., Ambrosini, G., Lelli, G., Mansutti, M., Verderio, P., Valagussa, P.

“…Background: To assess the efficacy of primary single-agent epirubicin (120 mg/m2 every 3 weeks for three cycles) in reducing tumor burden in operable breast…”
Get full text

Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study by von der Maase, H, Hansen, S W, Roberts, J T, Dogliotti, L, Oliver, T, Moore, M J, Bodrogi, I, Albers, P, Knuth, A, Lippert, C M, Kerbrat, P, Sanchez Rovira, P, Wersall, P, Cleall, S P, Roychowdhury, D F, Tomlin, I, Visseren-Grul, C M, Conte, P F

“…Gemcitabine plus cisplatin (GC) and methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) were compared in patients with locally advanced or metastatic…”
Get full text

Update and perspectives on non-surgical treatment of salivary gland malignancies by Airoldi, M, Cortesina, G, Giordano, C, Pedani, F, Cavalot, A, Marcato, P, Beatrice, F, Bumma, C

“…Surgery is the treatment of choice for major and minor salivary gland malignancies. Herein, the role of radiation and medical treatment in the…”
Get full text

Paclitaxel administration on days 1 and 8 every 21 days in anthracycline-pretreated metastatic breast cancer patients. A multicenter phase II trial by DONADIO, M, MANZIN, E, MORO, G, BERTETTO, O, BUMMA, C, DOGLIOTTI, L, BERRUTI, A, BOTTINI, A, GORZEGNO, G, DANESE, S, DEFABIANI, E, SAROBBA, M. G, LORUSSO, V, CASTIGLIONE, F

“…Paclitaxel is now included in second- and even first-line regimens in advanced breast cancer. The optimal dose and schedule of this drug, however, still remain…”
Get full text

Concomitant chemoradiotherapy followed by adjuvant chemotherapy in parotid gland undifferentiated carcinoma by Airoldi, M, Gabriele, A M, Gabriele, P, Pedani, F, Marchionatti, S, Succo, G, Beatrice, F, Bumma, C

“…Undifferentiated carcinoma of the parotid gland is a poor-prognosis lesion. Results in unresectable lesions, treated with radiotherapy alone, are very…”
Get full text

Ambulatory 4-day continuous-infusion schedule of high-dose ifosfamide with mesna uroprotection and granulocyte colony-stimulating factor in advanced solid tumours: a phase I study by Toma, S, Palumbo, R, Comandone, A, Oliva, C, Vincenti, M, Bumma, C, Rosso, R

“…There is evidence that continuous infusion allows the delivery of higher doses of a drug while reducing the incidence of neurologic and renal toxicity. To…”
Get more information

Phase III randomized study of fluorouracil, epirubicin, and cyclophosphamide v fluorouracil, doxorubicin, and cyclophosphamide in advanced breast cancer: an Italian multicentre trial by Ambrosini, G, Balli, M, Garusi, G, Demicheli, R, Jirillo, A, Bonciarelli, G, Bruscagnin, G, Fila, G, Bumma, C, Lacroix, F, Buzzi, F, Di Costanzo, F, Padalino, D, Brugia, M, Calabresi, F, Natali, M, Cartei, G, Chiesa, G, Blasina, B, Ciambellotti, E, Moro, G, D'Aquino, S, Altavilla, G, Adamo, V, De Maria, D, Falchi, A M, Bertoncelli, P, Farris, A, Fiorentino, M, Fornasiero, A, Fosser, V, Daniele, O, Foggi, C M, Speranza, G B, Sartori, S, Camilluzzi, E, Gallo, L, Poggio, R, Secondo, V, Gambi, A, Grignani, F, Capodicasa, E, Lopez, M, Papaldo, P, Di Lauro, L, Vici, P, Marenco, G, Folco, U, Bonanni, F, Marsilio, P, Palazzotto, G, Di Carlo, A, Cusimano, M P, Pastorino, G, Puccetti, C, Giusto, M, Rausa, L, Gebbia, N, Palmeri, S, D'Alessandro, N, Saccani, F, Becchi, G, Schieppati, G, Spinelli, I, Tagliagambe, A, Tonato, M, Minotti, V, Ardia, A, Viaro, D, De Micheli, P, Zingali, G, Sacchetti, G, Intini, C

“…From February 1983 to January 1985, 497 patients with advanced breast cancer were randomly allocated to receive either epirubicin or doxorubicin in the…”
Get more information

Combination of alpha‐interferon 2a (α‐IFN 2a) and 13‐CIS‐retinoic acid (13cRA) in recurrent, pre‐treated squamous‐cell carcinoma of head and neck (SCCHN) by Toma, S., Airoldi, M., Palumbo, R., Raffo, P., Bumma, C.

Get full text

Multicenter Phase II trial of intermediate dose cisplatin and vinorelbine in inoperable non-small cell lung cancer patients by Bretti, S., Berruti, A., Gorzegno, G., La Ciura, P., Pazè, E., Celano, A., Grecchi, G., Perroni, D., Bumma, C., Dogliotti, L.

“…Vinorelbine (VNB) and cisplatin (CDDP) combination regimen was found active in the treatment of advanced non-small cell lung cancer (NSCLC) patients, but…”
Get full text

Surgery for carcinoma of the gallbladder. Our experience by Leone, N, De Paolis, P, Garino, M, Brunello, F, Carrera, M, Pellicano, R, Fronda, G R, Bumma, C, Rizzetto, M

“…Carcinoma of the gallbladder is a gastrointestinal malignancy with a very poor prognosis. The 5-year survival rate amounts to less than 5% in most series. In…”
Get more information

Palmar-plantar erythrodysestasia syndrome associated with 5-fluorouracil treatment by Comandone, A, Bretti, S, La Grotta, G, Manzoni, S, Bonardi, G, Berardo, R, Bumma, C

“…Palmar-Plantar Erythrodysestasia Syndrome (PPES) or Hand-Foot Syndrome (H&F S) is an underestimated adverse reaction to chemotherapeutic agents, mainly related…”
Get more information

Pharmacokinetics of Ifosfamide Administered According to Three Different Schedules in Metastatic Soft Tissue and Bone Sarcomas by Comandone, A., Leone, L., Oliva, C., Frustaci, S., Monteleone, M., Colussi, A.M., Canton, O. Dal, Bergnolo, P., Boglione, A., Bumma, C.

“…Ifosfamide is a leading drug in soft tissue sarcoma therapy. Recently high dose therapy (>9 g/m 2 ) has been introduced in different schemes to obtain a higher…”
Get full text

Effects of Vinorelbine on quality of life and survival of elderly patients with advanced non-small-cell lung Cancer

Get full text

Vinorelbine for recurrent adenocarcinoma-like salivary gland malignancies by Airoldi, M., Bumma, C., Bertetto, O., Riella, A.M., Gabriele, P., Succo, G., Bussi, M.

Get full text

Head and neck metastases of renal cancer after nephrectomy: a report of 2 cases by Airoldi, M, Succo, G, Valente, G, Cavalot, A, Gabriele, P, Bumma, C

“…Two cases of metachronous metastases of renal cell adenocarcinoma are reported. One case presented a solitary metastasis of the ethmoid-orbit which was…”
Get more information

Non small cell lung cancer treatment with vinorelbine monochemotherapy: a phase II study by Clerici, M, Bretti, S, Celano, A, Panvini, D, Comandone, A, Casadio, C, Luporini, G, Bumma, C

“…Non small cell lung cancer is one of the leading causes of death in the industrial countries and some 70% of patients have non surgically eradicable disease…”
Get more information

Phase II randomized trial comparing vinorelbine versus vinorelbine plus cisplatin in patients with recurrent salivary gland malignancies by Airoldi, Mario, Pedani, Fulvia, Succo, Giovanni, Gabriele, Anna Maria, Ragona, Riccardo, Marchionatti, Sara, Bumma, Cesare

“…BACKGROUND Some previous studies have shown that vinorelbine (VNB) is active in recurrent salivary gland tumors. METHODS Between April 1993 and April 1997, 36…”
Get full text